These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36580191)

  • 1. Molecular alteration of the proteasome contributes to AD-like pathology in the brain of HFD-STZ diabetic rats.
    Gao H; Zhou Y; Jin PS; Wu DG; Wang YN; Zhao X; Zhao B
    Metab Brain Dis; 2023 Mar; 38(3):1013-1024. PubMed ID: 36580191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.
    Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA
    PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model.
    Sankar SB; Infante-Garcia C; Weinstock LD; Ramos-Rodriguez JJ; Hierro-Bujalance C; Fernandez-Ponce C; Wood LB; Garcia-Alloza M
    J Neuroinflammation; 2020 Jan; 17(1):38. PubMed ID: 31992349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome degradation of brain cytosolic tau in Alzheimer's disease.
    Yen SS
    Int J Clin Exp Pathol; 2011 Apr; 4(4):385-402. PubMed ID: 21577325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
    Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
    J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes.
    Khalaf SS; Hafez MM; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):685-695. PubMed ID: 30759264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice.
    Ramos-Rodriguez JJ; Ortiz O; Jimenez-Palomares M; Kay KR; Berrocoso E; Murillo-Carretero MI; Perdomo G; Spires-Jones T; Cozar-Castellano I; Lechuga-Sancho AM; Garcia-Alloza M
    Psychoneuroendocrinology; 2013 Nov; 38(11):2462-75. PubMed ID: 23790682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine attenuates the Alzheimer's disease related protein degradation and apoptotic neuronal death signalling.
    Gupta P; Tiwari S; Singh A; Pal A; Mishra A; Singh S
    Biochem J; 2021 Apr; 478(7):1435-1451. PubMed ID: 33660768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
    Miao Y; Guo D; Li W; Zhong Y
    J Alzheimers Dis; 2019; 69(1):289-296. PubMed ID: 30958383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
    Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.
    Morales-Corraliza J; Wong H; Mazzella MJ; Che S; Lee SH; Petkova E; Wagner JD; Hemby SE; Ginsberg SD; Mathews PM
    J Neurosci; 2016 Apr; 36(15):4248-58. PubMed ID: 27076423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Petry FR; Morin F; Planel E
    Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
    Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T
    Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain aging and AD-like pathology in streptozotocin-induced diabetic rats.
    Wang JQ; Yin J; Song YF; Zhang L; Ren YX; Wang DG; Gao LP; Jing YH
    J Diabetes Res; 2014; 2014():796840. PubMed ID: 25197672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats.
    Gomaa AA; Makboul RM; El-Mokhtar MA; Abdel-Rahman EA; Ahmed EA; Nicola MA
    Fundam Clin Pharmacol; 2021 Feb; 35(1):97-112. PubMed ID: 32602568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.
    Jung HJ; Kim YJ; Eggert S; Chung KC; Choi KS; Park SA
    Exp Neurol; 2013 Oct; 248():441-50. PubMed ID: 23906983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
    Chen JL; Zhang DL; Sun Y; Zhao YX; Zhao KX; Pu D; Xiao Q
    Neuroscience; 2017 Mar; 346():267-277. PubMed ID: 28147245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.
    Weng FL; He L
    Neurobiol Aging; 2021 Mar; 99():79-85. PubMed ID: 33422896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.